COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.
- DOI
- 10.1183/13993003.03969-2020
- Published
- 2021-12-09
- Container
- Eur Respir J
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1183/13993003.03969-2020,
title = {COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.},
author = {Weckmann M and Bahmer T and Sand JM and Rank Rønnow S and Pech M and Vermeulen C and Faiz A and Leeming DJ and Karsdal MA and Lunding L and Oliver BGG and Wegmann M and Ulrich-Merzenich G and Juergens UR and Duhn J and Laumonnier Y and Danov O and Sewald K and Zissler U and Jonker M and König I and Hansen G and von Mutius E and Fuchs O and Dittrich AM and Schaub B and Happle C and Rabe KF and van de Berge M and Burgess JK and Kopp MV and ALLIANCE Study Group as part of the German Centre for Lung Research (DZL).},
year = {2021},
journal = {Eur Respir J},
doi = {10.1183/13993003.03969-2020},
url = {https://doi.org/10.1183/13993003.03969-2020}
}RIS
TY - JOUR TI - COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. AU - Weckmann M AU - Bahmer T AU - Sand JM AU - Rank Rønnow S AU - Pech M AU - Vermeulen C AU - Faiz A AU - Leeming DJ AU - Karsdal MA AU - Lunding L AU - Oliver BGG AU - Wegmann M AU - Ulrich-Merzenich G AU - Juergens UR AU - Duhn J AU - Laumonnier Y AU - Danov O AU - Sewald K AU - Zissler U AU - Jonker M AU - König I AU - Hansen G AU - von Mutius E AU - Fuchs O AU - Dittrich AM AU - Schaub B AU - Happle C AU - Rabe KF AU - van de Berge M AU - Burgess JK AU - Kopp MV AU - ALLIANCE Study Group as part of the German Centre for Lung Research (DZL). PY - 2021 JO - Eur Respir J DO - 10.1183/13993003.03969-2020 UR - https://doi.org/10.1183/13993003.03969-2020 ER -
APA
M, W., T, B., JM, S., S, R. R., M, P., C, V., A, F., DJ, L., MA, K., L, L., BGG, O., M, W., G, U., UR, J., J, D., Y, L., O, D., K, S., U, Z., M, J., I, K., G, H., E, V. M., O, F., AM, D., B, S., C, H., KF, R., M, V. D. B., JK, B., MV, K., & (DZL)., A. S. G. A. P. O. T. G. C. F. L. R. (2021). COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.. Eur Respir J. https://doi.org/10.1183/13993003.03969-2020
Source records
- europe-pmc · retrieved 2026-09-25T21:15:42.975Z